PRAX
PRAX
NASDAQ · Biotechnology

Praxis Precision Medicines I

$300.65
+1.78 (+0.60%)
Analyst Consensus
Strong Buy
25
Analysts
High
Coverage
Buy 22 88%
Hold 2 8%
Sell 1 4%
Price Target
Analyst Price Target -93.5% upside
Low Target $15.93
Average Target $19.45
High Target $25.00
Current Price $300.65
Current
$300.65
Target
$19.45
$15.93 $19.45 avg $25.00
Scenario Analysis
Bear Case
$15.93
-94.7%
Low target
Base Case
$19.45
-93.5%
Avg target
Bull Case
$25.00
+-91.7%
High target
Risk/Reward
1.0x
Unfavorable
Price in Context
52-Week High
$392.70
-23.4% from high
52-Week Low
$41.78
+619.7% from low
50-Day SMA
$296.27
+1.5% vs SMA
200-Day SMA
$133.67
+124.9% vs SMA
RSI (14)
61.8
Neutral
Target vs 52W High
$19.45
-95.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.9%
AMGN
Amgen Inc
Hold 43 47% $190.87 -53.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.6%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -14.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
Hold 30 37% $149.45 -18.1%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -63.4%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -40.8%